Targeting Capillary Refill Time in Early Septic Shock Reduced Duration of Organ Support: Key Findings from ANDROMEDA‑SHOCK‑2
Highlights
– In a multinational randomized trial (ANDROMEDA‑SHOCK‑2), personalized hemodynamic resuscitation targeting capillary refill time (CRT) improved a hierarchical composite of death, duration of organ support, and length of stay (win ratio 1.16, 95% CI 1.02–1.33; P = .04).
– The primary benefit was a shorter duration of vital support (vasoactives, mechanical ventilation, kidney replacement therapy); mortality differences were small and not the main driver.
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.